Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
SaleOrdinary Shares | 3,394 | $71.97 | $244,266.18 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 8 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.85 to $72.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
SaleOrdinary Shares | 25,944 | $71.32 | $1,850,326.08 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 7 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,394 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.84 to $71.8307 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
SaleOrdinary Shares | 21,152 | $70.42 | $1,489,523.84 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 6 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,338 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.835 to $70.8248 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
SaleOrdinary Shares | 4,448 | $69.45 | $308,913.60 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 5 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,490 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.835 to $69.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
Exercise / conversionOrdinary Shares | 54,938 | $17.46 | $959,217.48 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 4 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
Exercise / conversionEmployee Share Option (Right to Buy) · Derivative | 28,553 | $0.00 Strike: $17.46 | $0.00 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · derivative · entry 9 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 363,237 Underlying: Ordinary Shares · 28,553 shares Expires 2028-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F8 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
SaleOrdinary Shares | 2,037 | $71.31 | $145,258.47 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 3 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.09 to $71.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
SaleOrdinary Shares | 26,516 | $70.60 | $1,872,029.60 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 2 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,037 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.09 to $71.088 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
Exercise / conversionOrdinary Shares | 28,553 | $17.46 | $498,535.38 |
DisclosureSEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 1 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:16 UTC |
St Leger Tina AmberCHIEF HR OFFICER
|
GrantEmployee Share Option (Right to Buy) · Derivative | 14,162 | $0.00 Strike: $70.50 | $0.00 |
DisclosureSEC source: 0001415889-24-004593 · form4-02212024_040226.xml · derivative · entry 1 St Leger Tina Amber · CIK 0001969525 · CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,162 Underlying: Ordinary Shares · 14,162 shares Expires 2034-02-15 F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:15 UTC |
Di Donato BrianCHIEF FINANCIAL OFFICER
|
GrantEmployee Share Option (Right to Buy) · Derivative | 66,746 | $0.00 Strike: $70.50 | $0.00 |
DisclosureSEC source: 0001415889-24-004592 · form4-02212024_040224.xml · derivative · entry 1 Di Donato Brian · CIK 0001766498 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,746 Underlying: Ordinary Shares · 66,746 shares Expires 2034-02-15 F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:15 UTC |
GOLL JOHNSVP, FINANCE & CAO
|
GrantEmployee Share Option (Right to Buy) · Derivative | 4,930 | $0.00 Strike: $70.50 | $0.00 |
DisclosureSEC source: 0001415889-24-004594 · form4-02212024_040229.xml · derivative · entry 1 GOLL JOHN · CIK 0001779466 · SVP, FINANCE & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,930 Underlying: Ordinary Shares · 4,930 shares Expires 2034-02-15 F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:15 UTC |
Berman David MHEAD OF R&D
|
GrantEmployee Share Option (Right to Buy) · Derivative | 111,244 | $0.00 Strike: $70.50 | $0.00 |
DisclosureSEC source: 0001415889-24-004591 · form4-02212024_040222.xml · derivative · entry 1 Berman David M · CIK 0001955244 · HEAD OF R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,244 Underlying: Ordinary Shares · 111,244 shares Expires 2034-02-15 F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:15 UTC |
Jallal BahijaDirector · CHIEF EXECUTIVE OFFICER
|
GrantEmployee Share Option (Right to Buy) · Derivative | 281,819 | $0.00 Strike: $70.50 | $0.00 |
DisclosureSEC source: 0001415889-24-004590 · form4-02212024_040209.xml · derivative · entry 1 Jallal Bahija · CIK 0001730038 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,819 Underlying: Ordinary Shares · 281,819 shares Expires 2034-02-15 F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:17 UTC |
St Leger Tina AmberChief HR Officer
|
Exercise / conversionEmployee Share Option (Right to Buy) · Derivative | 4,375 | $0.00 Strike: $29.87 | $0.00 |
DisclosureSEC source: 0001209191-24-001014 · doc4.xml · derivative · entry 4 St Leger Tina Amber · CIK 0001969525 · Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,375 Underlying: Ordinary Shares · 4,375 shares Expires 2032-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023. F4 · derivative.exercise_date: 25% of the shares subject to the option award vested on April 1, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:17 UTC |
St Leger Tina AmberChief HR Officer
|
SaleOrdinary Shares | 307 | $70.46 | $21,631.22 |
DisclosureSEC source: 0001209191-24-001014 · doc4.xml · nonDerivative · entry 3 St Leger Tina Amber · CIK 0001969525 · Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $70.66 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:17 UTC |
St Leger Tina AmberChief HR Officer
|
SaleOrdinary Shares | 4,068 | $69.85 | $284,149.80 |
DisclosureSEC source: 0001209191-24-001014 · doc4.xml · nonDerivative · entry 2 St Leger Tina Amber · CIK 0001969525 · Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.28 to $70.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:17 UTC |
St Leger Tina AmberChief HR Officer
|
Exercise / conversionOrdinary Shares | 4,375 | $29.87 | $130,681.25 |
DisclosureSEC source: 0001209191-24-001014 · doc4.xml · nonDerivative · entry 1 St Leger Tina Amber · CIK 0001969525 · Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.